Hamish Alan Cameron

Hamish Alan Cameron currently works at SV Health Investors LLP, as Venture Partner and The Royal College of Physicians, as Member.
Dr. Cameron also formerly worked at MedImmune Ltd., as Chief Executive Officer from 2006 to 2008, X2-Pharma GmbH, as Chief Executive Officer, Cell Medica Switzerland AG, as Chief Executive Officer & Director, TopiVert Ltd., as Chairman & Interim Chief Executive Officer, Artios Pharma Ltd., as Director, Affinium Pharmaceuticals Ltd., as Director, Faculty of Pharmaceutical Medicine, as Director, VHsquared Ltd., as Director, AstraZeneca PLC, as Senior Vice President-Medical Research, Janssen-Cilag Ltd., as Principal, and ESBATech, a Novartis Co. GmbH, as Chief Commercial Officer.
Dr. Cameron received his undergraduate degree and doctorate degree from the University of London.